MedicGo
Oral submucous fibrosis and COVID-19: Perspective on comorbidity.
Metadata
Journaloral oncology3.979Date
2020 May 21
4 months ago
Type
Letter
Volume
2020-08 / 107 : 104811
Author
Sarode SC 1, Sarode GS 2, Gondivkar S 3, Gadbail A 4, Gopalakrishnan D 5, Patil S 6
Affiliation
  • 2. Department of Oral Pathology and Microbiology, Dr. D.Y. Patil Dental College and Hospital, Dr. D.Y. Patil Vidyapeeth, Sant-Tukaram Nagar, Pimpri, Pune 411018, MH, India.
  • 3. Department of Oral Medicine and Radiology, Government Dental College & Hospital, Nagpur, Maharashtra, India.
  • 4. Department of Dentistry, Indira Gandhi Government Medical College and Hospital, Nagpur, Maharashtra, India.
  • 5. Department of Periodontology & Oral Implantology, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, Maharashtra, India.
  • 6. Department of Maxillofacial Surgery and Diagnostic Sciences, Division of Oral Pathology, College of Dentistry, Jazan University, Jazan, Saudi Arabia.
Doi
PMIDMESH
Angiotensin II
Betacoronavirus
Comorbidity
Coronavirus Infections
Down-Regulation
Humans
Mouth
Oral Submucous Fibrosis
Pandemics
Peptidyl-Dipeptidase A
Pneumonia, Viral
Prevalence
Spike Glycoprotein, Coronavirus
Fav
Like
Download
Share
Export
Cite
4.0
Oral Oncoloral oncology
Metadata
LocationEngland
FromELSEVIER

No Data

© 2017 - 2020 Medicgo
Powered by some medical students